Efficacy & Safety of KAPVAY™ Extended-Release in Children & Adolescents With Attention Deficit Hyperactivity Disorder
Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the long-term efficacy and safety of KAPVAY™
(clonidine hydrochloride) extended-release in children and adolescents with Attention Deficit
Hyperactivity Disorder (ADHD)